Author name: Leonardo Arias

Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, actively working to remove obstacles to innovation.

The financing comes 11 months after Cornerstone raised $70 million to support the launch of its device in China.

Speaking at a conference this morning, Pfizer CEO Albert Bourla suggested that Metsera’s therapies could begin hitting the market in 2028.

The pandemic-era virtual care policies are back in place through Jan. 30. But short-term deals aren’t sustainable, telehealth advocates and providers say.

Only 41% of rural hospitals in the U.S. deliver babies, according to a report by the Center for Healthcare Quality and Payment Reform. In some states, fewer than one-third of these facilities offer labor and delivery services.

The House passed a stopgap funding bill and President Donald Trump signed it late Wednesday, reopening the government without a clear path forward on preserving enhanced subsidies for ACA plans — Democrats’ chief demand.

The decision is a “natural next step in our journey to becoming a fully independent company,” Siemens Healthineers CEO Bernd Montag said.

Korro Bio is moving back to square one as a preclinical biotech after the failure of KRRO-110 in alpha-1 antitrypsin deficiency. The company’s stock is down 80% on all the news.

Unpredictable communication and a lack of transparency are eroding the industry’s and the public’s trust. The FDA, experts agree, needs to take control of the narrative.

The House passed a stopgap funding bill and President Donald Trump signed it late Wednesday, reopening the government without a clear path forward on preserving enhanced subsidies for ACA plans — Democrats’ chief demand.